Trademark: 98053336
Word
EYZURCI
Status Date
Monday, April 22, 2024
Filing Date
Wednesday, June 21, 2023
5 pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure
Jun 24, 2023
New Application Entered
Jun 29, 2023
New Application Office Supplied Data Entered
Dec 5, 2023
Assigned To Examiner
Dec 20, 2023
Application Extension To Response Period - Received
Dec 7, 2023
Non-Final Action Written
Dec 7, 2023
Non-Final Action E-Mailed
Dec 7, 2023
Notification Of Non-Final Action E-Mailed
Dec 20, 2023
Application Extension Granted/Receipt Provided
Apr 15, 2024
Teas/Email Correspondence Entered
Apr 15, 2024
Correspondence Received In Law Office
Apr 15, 2024
Teas Response To Office Action Received
Apr 22, 2024
Approved For Pub - Principal Register
Trademark Alertz updated from USPTO on 2030-01-24